Business Value: Haleon plc (HLN)

Brandmark of Haleon plc (HLN)

The price chart for Haleon plc (HLN) on the GURU.Markets platform serves as an indicator for a business that relies on brand recognition and production scale, with the current metric standing at 47623.57. Simultaneously, Haleon plc is modernizing its plants by implementing smart warehouse management systems and automation. Distribution efficiency is ensured through wholesale deliveries to pharmacies, which minimizes product transportation costs.

HLN: Haleon PLC Enterprise Value 11/23/2025 - 10/30/2026

Summary analytical data breakdowns for Haleon plc (HLN)

- stock price and consensus target price:
Price Chart Haleon PLC|HLN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Haleon|HLN - Total Company Value
- balance sheet net asset value indicators:
Share Book Value Haleon|HLN - Book Capitalization|Market Value to Book Value haleon.com|HLN - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Haleon plc|HLN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital haleon.com|HLN - Company Debts|Debt to Book Value Haleon|HLN - Company Long-Term Debts|Company Short-Term Debts Haleon|Intermediate Coverage Ratio haleon.com
- earnings and valuation multiples information:
HLN - Company Net Income
Analysis of all company metrics:HLN - Haleon PLC
Original product of haleon.com

This indicator is critically important for Haleon plc, as it allows for an assessment of how the debt load following the spin-off from GSK and the Zantac litigation claims impact the overall business value. By analyzing the company's actual market price, an investor sees the sum of market capitalization and net debt, which reflects the total cost of acquiring the asset, accounting for all liabilities and cash reserves.

Who Haleon plc competes with

Kenvue Inc - Total Company Value|VRNA - Total Company Value|MENS (Jyong Bio) - Business Value|Ligand Pharmaceuticals (LGND) - Total Company Value|Full Business Value AMRX (amneal.com)|PRGO (Perrigo) - Enterprise Value|ALVO: Value Adjusted for Debt and Cash|Enterprise Value LQDA|Enterprise Value Galapagos Corp (GLPG)|Total Company Value ANI Pharmaceuticals ANIP|Value Adjusted for Debt and Cash MNKD|AMPH - Total Company Value|Pacira Pharmaceuticals (PCRX) - Real Price to Acquire Entire Company|SPRY: Enterprise Value|Theravance Corp (TBPH) - Enterprise Value|Real Price to Acquire Entire Company AQST|SCPH: Value Adjusted for Debt and Cash|Total Company Value Tectonic Therapeutic, Inc. (TECX)|TNXP - Total Enterprise Value|China SXT Pharmaceuticals, Inc. - Real Price to Acquire Entire Company|Aggregate Business Value EPRX (Eupraxia Pharmaceuticals, Inc.)|BioHarvest Sciences - Enterprise Value|Value Adjusted for Debt and Cash EXOZ (invizyne.com)|ORMP: Enterprise Value|Total Enterprise Value Entera Bio (ENTX)|Total Company Value MindWalk|ABVC: Value Adjusted for Debt and Cash|Enterprise Value CPIX|QNTM (quantumbiopharma.com) - Value Adjusted for Debt and Cash|Enterprise Value FGEN (FibroGen)|Enterprise Value Telomir Pharmaceuticals Inc TELO|RANI - Total Company Value|SNYR: Total Company Value|RLYB: Enterprise Value|Total Enterprise Value Lexaria Bioscience Corp. (LEXX)|Total Company Value Pulmatrix|Total Enterprise Value Pheton PTHL|Total Company Value Aptorum Group Limited (APM)|Lyra Therapeutics Inc - Business Value|Impact BioMedical - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash TNFA|YCBD - Total Company Value|Full Business Value PRFX|altamiratherapeutics.com (CYTO) - Total Company Value|LIPO (Lipella Pharma) - Total Company Value|OPTN (OptiNose, Inc.) - Enterprise Value|Real Price to Acquire Entire Company pieris.com (PIRS)|Enterprise Value PROC|PTPI (Petros Pharmaceuticals Inc) - Value Adjusted for Debt and Cash|Total Company Value Qilian International Holding Group Limited QLI|ACELYRIN Inc. - Total Company Value|TFFP - Total Company Value